FSD Pharma (FSDDF) Stock Price, News & Analysis

Company Overview

FSD Pharma, Inc. is a specialty biotech pharmaceutical research and development company. It focuses on developing over time a robust pipeline of FDA-approved synthetic compounds targeting the endocannabinoid system of the human body to treat certain diseases of the central nervous system and autoimmune disorders of the skin, GI tract, and the musculoskeletal system. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz in 1994 and is headquartered in Cobourg, Canada.

Key Stats

• Today's Range: $18.36 to $21.66
• 50-Day Range: $6.18 to $19.69
• 52-Week Range: $3.43 to $68.66
• Volume: 447,638 shs
• Average Volume: 11,100 shs
• Market Capitalization: $149.25 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

FSDDF Stock Analysis - Frequently Asked Questions

How have FSDDF shares performed this year?

FSD Pharma's stock was trading at $3.68 at the start of the year. Since then, FSDDF stock has increased by 435.1% and is now trading at $19.69.
View the best growth stocks for 2025 here.

How do I buy shares of FSD Pharma?

Shares of FSDDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Agricultural Commodities & Milling
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:FSDDF
• CIK: N/A
• Web: N/A
• Phone: (416) 854-8884
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.81
• Quick Ratio: 1.60

Sales & Book Value

• Annual Sales: $70 thousand
• Price / Sales: 2,132.15
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 7,580,000
• Free Float: N/A
• Market Cap: $149.25 million
• Optionable: Not Optionable
• Beta: N/A